DALE WEBSTER: Open Payments
NPI 1992790372 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$922 in 49 payments from 9 companies in 2025. Trend: 2023 $988 · 2024 $1,061 · 2025 $922
Food & beverage: $922
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 34 | $592 |
| Cleerly, Inc. | 2 | $94 |
| PFIZER INC. | 4 | $79 |
| Medtronic, Inc. | 3 | $69 |
| Amgen Inc. | 2 | $27 |
| SCPHARMACEUTICALS INC. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| BridgeBio Pharma, Inc. | 1 | $14 |
| CVRx, Inc. | 1 | $13 |
Products named: LEQVIO, Cleerly Ischemia, ELIQUIS, MICRA, REPATHA, MYCARELINK, FUROSCIX, FARXIGA.
Industry payments across NY — which companies pay providers there.
